Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.23B |
| 2 |
Abbott
ABT
|
+$1.36B |
| 3 |
Honeywell
HON
|
+$959M |
| 4 |
EOG Resources
EOG
|
+$769M |
| 5 |
Emerson Electric
EMR
|
+$708M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.84B |
| 2 |
TJX Companies
TJX
|
+$1.53B |
| 3 |
Baxter International
BAX
|
+$1.23B |
| 4 |
Amazon
AMZN
|
+$1.1B |
| 5 |
Apple
AAPL
|
+$935M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.3% |
| 2 | Technology | 15.48% |
| 3 | Financials | 14.45% |
| 4 | Industrials | 11.06% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Signet Jewelers
SIG
$3.75B
| $845K | ﹤0.01% |
+12,433
| New | +$792K |
|
1602
Oneok
OKE
$54.7B
| $844K | ﹤0.01% |
12,842
+1,814
| +16% | +$111K |
|
1603
ResMed
RMD
$32.3B
| $843K | ﹤0.01% |
+4,050
| New | +$890K |
|
1604
West Pharmaceutical
WST
$24.6B
| $834K | ﹤0.01% |
3,545
+195
| +6% | +$46.2K |
|
1605
JPMorgan BetaBuilders Europe ETF
BBEU
$9.47B
| $834K | ﹤0.01% |
17,200
-900
| -5% | -$41.4K |
|
|
CSW
1606
CSW Industrials
CSW
$5.66B
| $832K | ﹤0.01% |
7,176
-269
| -4% | -$32.2K |
|
|
GRMN
1607
Garmin
GRMN
$58.8B
| $831K | ﹤0.01% |
9,005
-5,439
| -38% | -$481K |
|
1608
Hartford Multifactor US Equity ETF
ROUS
$715M
| $827K | ﹤0.01% |
21,195
-1,169
| -5% | -$45.2K |
|
1609
Heron Therapeutics
HRTX
$94.8M
| $817K | ﹤0.01% |
326,654
-6,257
| -2% | -$20.2K |
|
1610
Annaly Capital Management
NLY
$17.1B
| $813K | ﹤0.01% |
38,544
-1,294,995
| -97% | -$25.5M |
|
1611
Toast
TOST
$20.1B
| $805K | ﹤0.01% |
+44,652
| New | +$839K |
|
1612
Nurix Therapeutics
NRIX
$2.58B
| $802K | ﹤0.01% |
73,004
-1,525
| -2% | -$18.4K |
|
1613
Dave & Buster's
PLAY
$356M
| $797K | ﹤0.01% |
+22,480
| New | +$813K |
|
1614
Mid-America Apartment Communities
MAA
$15.6B
| $796K | ﹤0.01% |
5,070
+939
| +23% | +$146K |
|
1615
C4 Therapeutics
CCCC
$398M
| $795K | ﹤0.01% |
134,781
+67,177
| +99% | +$557K |
|
1616
Sensient Technologies
SXT
$5.49B
| $795K | ﹤0.01% |
10,905
+5,346
| +96% | +$383K |
|
|
DOOR
1617
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $787K | ﹤0.01% |
+9,766
| New | +$721K |
|
1618
Envista
NVST
$4.55B
| $784K | ﹤0.01% |
+23,291
| New | +$797K |
|
1619
DTE Energy
DTE
$29B
| $783K | ﹤0.01% |
+6,662
| New | +$755K |
|
1620
Neogen
NEOG
$2.52B
| $781K | ﹤0.01% |
51,299
+21,664
| +73% | +$309K |
|
|
MPT
1621
Medical Properties Trust
MPT
$2.76B
| $781K | ﹤0.01% |
70,072
-12,250,337
| -99% | -$142M |
|
|
SBNY
1622
DELISTED
Signature Bank
SBNY
| $777K | ﹤0.01% |
6,747
-483,701
| -99% | -$66.5M |
|
1623
Karyopharm Therapeutics
KPTI
$45.1M
| $777K | ﹤0.01% |
15,241
-1,101
| -7% | -$76.3K |
|
1624
O-I Glass
OI
$1.16B
| $776K | ﹤0.01% |
+46,808
| New | +$754K |
|
1625
Old Republic International
ORI
$10.5B
| $775K | ﹤0.01% |
32,090
-25,791
| -45% | -$605K |
|
Similar funds
Wellington Management Group's Q4 2022 Portfolio in Review
As of Q4 2022, Wellington Management Group held 2,204 positions worth $499B, up 6.2% from $469B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Wellington Management Group withdrew a net $16.1B in Q4 2022, closing 226 positions and reducing 867 holdings. Its most notable exit was Abiomed Inc, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
Against the trend, Wellington Management Group opened a new position in U-Haul Holding Co Series N worth $209M.
- Wellington Management Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 3,802,513 shares worth $209M.
- Wellington Management Group added most to Merck in Q4 2022, an estimated $2.23B increase.
- Wellington Management Group's biggest Q4 2022 reduction was Bristol-Myers Squibb, cutting an estimated $1.84B.
- Wellington Management Group fully exited Abiomed Inc in Q4 2022, selling an estimated $357M.
- Wellington Management Group's ten largest holdings make up 17% of its $499B portfolio in Q4 2022.
- Wellington Management Group opened 185 new positions and closed 226 in Q4 2022.
- Wellington Management Group's portfolio value rose 6.2% quarter-over-quarter to $499B.
Based on Wellington Management Group's 13F filing for Q4 2022, filed 13 Feb 2023.